These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 17351872)
21. The large scale restructuring of pharmaceutical company research function. Preface. Lawton G; Witty DR Prog Med Chem; 2012; 51():v-vi. PubMed ID: 22520474 [No Abstract] [Full Text] [Related]
22. Optical imaging in drug discovery and diagnostic applications. Licha K; Olbrich C Adv Drug Deliv Rev; 2005 Jun; 57(8):1087-108. PubMed ID: 15908041 [TBL] [Abstract][Full Text] [Related]
23. Pharmacogenomic approaches in clinical studies to identify biomarkers of safety and efficacy. Burczynski ME Toxicol Lett; 2009 Apr; 186(1):18-21. PubMed ID: 19022363 [TBL] [Abstract][Full Text] [Related]
27. Personalized medicine: a paradigm for a sustainable pharmaceutical industry? Chackalamannil S; Desai MC Curr Opin Drug Discov Devel; 2009 Jul; 12(4):443-5. PubMed ID: 19562640 [TBL] [Abstract][Full Text] [Related]
28. Toward personalized medicine in the neuropsychiatric field. Wong EH; Fox JC; Ng MY; Lee CM Int Rev Neurobiol; 2011; 101():329-49. PubMed ID: 22050858 [TBL] [Abstract][Full Text] [Related]
29. Genaissance pharmaceuticals, inc. Oestreicher P Pharmacogenomics; 2002 Mar; 3(2):273-6. PubMed ID: 11972448 [TBL] [Abstract][Full Text] [Related]
30. Deal watch: Trends in platform technology deal-making. Walker J; Jacob J Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395 [No Abstract] [Full Text] [Related]
31. Integrating genomics across drug discovery and development. Debouck C Toxicol Lett; 2009 Apr; 186(1):9-12. PubMed ID: 18930125 [TBL] [Abstract][Full Text] [Related]
32. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium. Razvi ES IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794 [No Abstract] [Full Text] [Related]
33. Future approaches of nanomedicine in clinical science. Brewer M; Zhang T; Dong W; Rutherford M; Tian ZR Med Clin North Am; 2007 Sep; 91(5):963-1016. PubMed ID: 17826113 [TBL] [Abstract][Full Text] [Related]
34. Translational research in oncology: key bottlenecks and new paradigms. Simon R Expert Rev Mol Med; 2010 Oct; 12():e32. PubMed ID: 20929594 [TBL] [Abstract][Full Text] [Related]
35. Integrating research and development: the emergence of rational drug design in the pharmaceutical industry. Adam M Stud Hist Philos Biol Biomed Sci; 2005 Sep; 36(3):513-37. PubMed ID: 16137601 [TBL] [Abstract][Full Text] [Related]
36. Global strategic partnerships in regenerative medicine. French A; Suh JY; Suh CY; Rubin L; Barker R; Bure K; Reeve B; Brindley DA Trends Biotechnol; 2014 Sep; 32(9):436-40. PubMed ID: 25150363 [TBL] [Abstract][Full Text] [Related]
37. Open access chemical and clinical probes to support drug discovery. Edwards AM; Bountra C; Kerr DJ; Willson TM Nat Chem Biol; 2009 Jul; 5(7):436-40. PubMed ID: 19536100 [TBL] [Abstract][Full Text] [Related]
38. Assessing patient readiness for the clinical adoption of personalized medicine. Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419 [TBL] [Abstract][Full Text] [Related]
39. Pharmaceutical companies and ophthalmic research. Liesegang TJ; Schachat AP; Albert DA Ophthalmology; 2005 Mar; 112(3):363-5. PubMed ID: 15745760 [No Abstract] [Full Text] [Related]